ZYNE 1.3 (+0%)
US98986X1090• Drug Manufacturers• Drug Manufacturers - Specialty & Generic
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. ZYNE

Zynerba Pharmaceuticals (ZYNE) Stock Highlights

1.3 | +0%
2023-11-16 16:21:15
Zynerba Pharmaceuticals Inc is a pharmaceutical company that is focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product pipeline consists Zygel which is a pharmaceutically-produced CBD, a non-euphoric cannabinoid, formulated as a patent-protected permeation-enhanced gel for transdermal delivery through the skin and into the circulatory system.

Statistics

Range Today
1.3 1.3
Volume Today 0
Range 1 Year
0.25 1.4
Volume 1 Year 114.56M
Range 3 Year
0.25 9
Volume 3 Year 880.33M
Range 10 Year
0.25 43
Volume 10 Year 1.74B

Highlights

Market Capitalization 18.72M (micro)
Floating Shares 46.68M
Current Price 1.3
Price To Earnings -0.41
Price To Book 0.45
Earnings Per Share -0.85
Payout Ratio 0%

Performance

Latest 0%
1 Month -1.52%
3 Months +271.43%
6 Months +225%
1 Year +94.03%
3 Years -64.48%
5 Years -82.07%
10 Years -92.78%

Benchmarks

Market Capitalization

47 / 54

Gross Profits

0 / 39

Total Revenue

0 / 50

Total Rank

24 / 54

Free Cashflow

40 / 54

Performance 5 years

38 / 54

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.